Document Detail


Changes in Aortic Pulse Wave Velocity in Hypertensive Postmenopausal Women: Comparison Between a Calcium Channel Blocker vs Angiotensin Receptor Blocker Regimen.
MedLine Citation:
PMID:  23126349     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
J Clin Hypertens (Greenwich). 2012;14:773-778. ©2012 Wiley Periodicals, Inc. Postmenopausal women are at greater risk for hypertension-related cardiovascular disease. Antihypertensive therapy may help alleviate arterial stiffness that represents a potential modifiable risk factor of hypertension. This randomized controlled study investigated the difference between an angiotensin receptor blocker and a calcium channel blocker in reducing arterial stiffness. Overall, 125 postmenopausal hypertensive women (age, 61.4±6 years; systolic blood pressure/diastolic blood pressure [SBP/DBP], 158±11/92±9 mm Hg) were randomized to valsartan 320 mg±hydrochlorothiazide (HCTZ) (n=63) or amlodipine 10 mg±HCTZ (n=62). The primary outcome was carotid-to-femoral pulse wave velocity (PWV) changes after 38 weeks of treatment. Both treatments lowered peripheral blood pressure (BP) (-22.9/-10.9 mm Hg for valsartan and -25.2/-11.7 mm Hg for amlodipine, P=not significant) and central BP (-15.7/-7.6 mm Hg for valsartan and -19.2/-10.3 mm Hg for amlodipine, P<.05 for central DBP). Both treatments similarly reduced the carotid-femoral PWV (-1.9 vs -1.7 m/s; P=not significant). Amlodipine was associated with a higher incidence of peripheral edema compared with the valsartan group (77% vs 14%, P<.001). BP lowering in postmenopausal women led to a reduction in arterial stiffness as assessed by PWV measurement. Both regimens reduced PWV to a similar degree after 38 weeks of treatment despite differences in central BP lowering, suggesting that the effect of valsartan on PWV is mediated through nonhemodynamic effects.
Authors:
Daniel Hayoz; Dion H Zappe; Marie A R Meyer; Inyoung Baek; Albert Kandra; Marie P Joly; Lucia Mazzolai; Erik Haesler; Daniel Periard
Related Documents :
6614279 - The effect of the dental setting on blood pressure measurement.
12889219 - Assessment of kidney involvement.
3228529 - Direct mail as a prompt for follow-up care among persons at risk for hypertension.
10972219 - Intragraft expression of transforming growth factor-beta 1 by a novel quantitative reve...
23280869 - Characteristics of hypertension in chinese and their relevance for the choice of antihy...
19357029 - Role of 2-dimensional doppler echo-cardiography in screening portopulmonary hypertensio...
9843869 - Characterization of responses to neurokinin a in the isolated perfused guinea pig heart.
1541129 - Spontaneous breathing and total body oxygen consumption in children recovering from ope...
7463879 - Relationships between hypothalamic catecholamines, blood pressure and body temperature ...
Publication Detail:
Type:  Journal Article     Date:  2012-09-12
Journal Detail:
Title:  Journal of clinical hypertension (Greenwich, Conn.)     Volume:  14     ISSN:  1751-7176     ISO Abbreviation:  J Clin Hypertens (Greenwich)     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-06     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888554     Medline TA:  J Clin Hypertens (Greenwich)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  773-8     Citation Subset:  IM    
Copyright Information:
© 2012 Wiley Periodicals, Inc.
Affiliation:
From the Department of Medicine, Hospital Cantonal Fribourg, Fribourg, Switzerland;the Department of Medicine, Vascular Medicine CHUV, Lausanne, Switzerland;the Novartis Pharmaceuticals Corporation, East Hanover, NJ;and the Novartis Pharma AG, Basel, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lifestyle educational program strongly increases compliance to nonpharmacologic intervention in hype...
Next Document:  Elderly hypertensives: how are they different?